Response to energy depletion: miR-451/AMPK loop
Response to energy depletion: miR-451/AMPK loop |
|
https://doi.org/10.18632/oncotarget.4606
Agnieszka Bronisz,
E. Antonio Chiocca,
and Jakub Godlewski
|
| 17851-17852 |
Mitotic transformation of TRAMM/TrappC12
Mitotic transformation of TRAMM/TrappC12 |
|
https://doi.org/10.18632/oncotarget.4843
Miroslav P. Milev,
and Michael Sacher
|
| 17853-17854 |
Trithorax group genes in hematopoiesis
Trithorax group genes in hematopoiesis |
|
https://doi.org/10.18632/oncotarget.4882
Jennifer Chase,
Jolanta Grembecka,
and Ivan Maillard
|
| 17855-17856 |
Cell therapy - showing cells the way home
Cell therapy - showing cells the way home |
|
https://doi.org/10.18632/oncotarget.4883
Martina Heinelt,
Jeffrey M. Karp,
and Oren Levy
|
| 17857-17858 |
Regulation of the polo kinase during cytokinesis
Regulation of the polo kinase during cytokinesis |
|
https://doi.org/10.18632/oncotarget.4885
David Kachaner
|
| 17859-17860 |
Repressing the repressor: Fra1 controls plasma cell generation
Repressing the repressor: Fra1 controls plasma cell generation |
|
https://doi.org/10.18632/oncotarget.5015
Dirk Mielenz,
Bettina Grötsch,
and Jean-Pierre David
|
| 17861-17862 |
Trafficking of lymphocytes into the CNS
Trafficking of lymphocytes into the CNS |
|
https://doi.org/10.18632/oncotarget.5014
Nicholas Schwab,
Tilman Schneider-Hohendorf,
and Heinz Wiendl
|
| 17863-17864 |
“CRISPR” validation of recessive brain cancer genes in vivo
“CRISPR” validation of recessive brain cancer genes in vivo |
|
https://doi.org/10.18632/oncotarget.4864
Marc Zuckermann,
Daisuke Kawauchi,
and Jan Gronych
|
| 17865-17866 |
Closing in on life: proximity dependent methods for life sciences
Closing in on life: proximity dependent methods for life sciences |
|
https://doi.org/10.18632/oncotarget.4890
Björn Koos,
and Ola Söderberg
|
| 17867-17868 |
Regnase-1 and Roquin regulate inflammatory mRNAs
Regnase-1 and Roquin regulate inflammatory mRNAs |
|
https://doi.org/10.18632/oncotarget.4891
Takashi Mino,
and Osamu Takeuchi
|
| 17869-17870 |
WISp39 and Hsp90: actin' together in cell migration
WISp39 and Hsp90: actin' together in cell migration |
|
https://doi.org/10.18632/oncotarget.4934
Rati Fotedar,
and Robert L. Margolis
|
| 17871-17872 |
RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy
RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy |
|
https://doi.org/10.18632/oncotarget.4286
Paola Indovina,
Francesca Pentimalli,
Nadia Casini,
Immacolata Vocca,
and Antonio Giordano
|
| 17873-17890 |
Intron-based genomic editing: a highly efficient method for generating knockin zebrafish
Intron-based genomic editing: a highly efficient method for generating knockin zebrafish |
|
https://doi.org/10.18632/oncotarget.4547
Jia Li,
Baibing Zhang,
Jiwen Bu,
and Jiulin Du
|
| 17891-17894 |
Point mutations of the mTOR-RHEB pathway in renal cell carcinoma
Point mutations of the mTOR-RHEB pathway in renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.4963
Arindam P. Ghosh,
Christopher B. Marshall,
Tatjana Coric,
Eun-hee Shim,
Richard Kirkman,
Mary E. Ballestas,
Mitsuhiko Ikura,
Mary-Ann Bjornsti,
and Sunil Sudarshan
|
| 17895-17910 |
Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis
Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis |
|
https://doi.org/10.18632/oncotarget.3772
Mohammed Soutto,
Judith Romero-Gallo,
Uma Krishna,
Blanca M. Piazuelo,
Kay M. Washington,
Abbes Belkhiri,
Richard M. Peek,
and Wael El-Rifai
|
| 17911-17922 |
Mitochondrial morphology is altered in atrophied skeletal muscle of aged mice
Mitochondrial morphology is altered in atrophied skeletal muscle of aged mice |
|
https://doi.org/10.18632/oncotarget.4235
Jean-Philippe Leduc-Gaudet,
Martin Picard,
Félix St-Jean Pelletier,
Nicolas Sgarioto,
Marie-Joëlle Auger,
Joanne Vallée,
Richard Robitaille,
David H. St-Pierre,
and Gilles Gouspillou
|
| 17923-17937 |
Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence
Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence |
|
https://doi.org/10.18632/oncotarget.4852
Ping Niu,
Aibek Smagul,
Lu Wang,
Aiman Sadvakas,
Ying Sha,
Laura M. Pérez,
Aliya Nussupbekova,
Aday Amirbekov,
Akan A. Akanov,
Beatriz G. Gálvez,
I. King Jordan,
and Victoria V. Lunyak
|
| 17938-17957 |
Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma
Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma |
|
https://doi.org/10.18632/oncotarget.4641
Min Wang,
Ping Chen,
Yan Jia,
Na He,
Daqi Li,
Chunyan Ji,
and Daoxin Ma
|
| 17958-17967 |
Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice
Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice |
|
https://doi.org/10.18632/oncotarget.4956
Amanda M. Goh,
Yuezhen Xue,
Marc Leushacke,
Ling Li,
Julin S. Wong,
Poh Cheang Chiam,
Siti Aishah Binte Rahmat,
Michael B. Mann,
Karen M. Mann,
Nick Barker,
Guillermina Lozano,
Tamara Terzian,
and David P. Lane
|
| 17968-17980 |
Identification of TAX2 peptide as a new unpredicted anti-cancer agent
Identification of TAX2 peptide as a new unpredicted anti-cancer agent |
|
https://doi.org/10.18632/oncotarget.4025
Albin Jeanne,
Emilie Sick,
Jérôme Devy,
Nicolas Floquet,
Nicolas Belloy,
Louis Theret,
Camille Boulagnon-Rombi,
Marie-Danièle Diebold,
Manuel Dauchez,
Laurent Martiny,
Christophe Schneider,
and Stéphane Dedieu
|
| 17981-18000 |
Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor
Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor |
|
https://doi.org/10.18632/oncotarget.4534
Jason Chesney,
Jennifer Clark,
Lilibeth Lanceta,
John O. Trent,
and Sucheta Telang
|
| 18001-18011 |
The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis
The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis |
|
https://doi.org/10.18632/oncotarget.4000
Tzu-Ting Huang,
Yueh-Hsin Ping,
An-Ming Wang,
Chia-Chi Ke,
Wen-Liang Fang,
Kuo-Hung Huang,
Hsin-Chen Lee,
Chin-Wen Chi,
and Tien-Shun Yeh
|
| 18012-18026 |
Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells
Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells |
|
https://doi.org/10.18632/oncotarget.4090
Lixia Wang,
Xiantao Ye,
Xingming Cai,
Jingna Su,
Renqiang Ma,
Xuyuan Yin,
Xiuxia Zhou,
Huabin Li,
and Zhiwei Wang
|
| 18027-18037 |
Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis
Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis |
|
https://doi.org/10.18632/oncotarget.3833
Samira M. Sadowski,
Myriem Boufraqech,
Lisa Zhang,
Amit Mehta,
Payal Kapur,
Yaqin Zhang,
Zhuyin Li,
Min Shen,
and Electron Kebebew
|
| 18038-18049 |
XB130 translocation to microfilamentous structures mediates NNK-induced migration of human bronchial epithelial cells
XB130 translocation to microfilamentous structures mediates NNK-induced migration of human bronchial epithelial cells |
|
https://doi.org/10.18632/oncotarget.3777
Qifei Wu,
Jeya Nadesalingam,
Serisha Moodley,
Xiaohui Bai,
and Mingyao Liu
|
| 18050-18065 |
Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature
Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature |
|
https://doi.org/10.18632/oncotarget.3768
Shu-Jen Chen,
Hsuan Liu,
Chun-Ta Liao,
Po-Jung Huang,
Yi Huang,
Ann Hsu,
Petrus Tang,
Yu-Sun Chang,
Hua-Chien Chen,
and Tzu-Chen Yen
|
| 18066-18080 |
Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation
Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation |
|
https://doi.org/10.18632/oncotarget.4018
Takayuki Kimura,
Makoto Sugaya,
Tomonori Oka,
Andrew Blauvelt,
Hitoshi Okochi,
and Shinichi Sato
|
| 18081-18093 |
rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis
rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis |
|
https://doi.org/10.18632/oncotarget.4093
Sandeep S. Negi,
and Patrick Brown
|
| 18094-18104 |
Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors
Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors |
|
https://doi.org/10.18632/oncotarget.3906
Jinquan Cai,
Jing Chen,
Wei Zhang,
Pei Yang,
Chuanbao Zhang,
Mingyang Li,
Kun Yao,
Hongjun Wang,
Qingbin Li,
Chuanlu Jiang,
and Tao Jiang
|
| 18105-18115 |
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion |
|
https://doi.org/10.18632/oncotarget.4016
Ada Pesapane,
Carmen Di Giovanni,
Francesca Wanda Rossi,
Daniela Alfano,
Luigi Formisano,
Pia Ragno,
Carmine Selleri,
Nunzia Montuori,
and Antonio Lavecchia
|
| 18116-18133 |
Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion
Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion |
|
https://doi.org/10.18632/oncotarget.4017
Claudio Pulito,
Federica Mori,
Andrea Sacconi,
Luca Casadei,
Maria Ferraiuolo,
Maria Cristina Valerio,
Raffaela Santoro,
Frauke Goeman,
Anna Maidecchi,
Luisa Mattoli,
Cesare Manetti,
Silvia Di Agostino,
Paola Muti,
Giovanni Blandino,
and Sabrina Strano
|
| 18134-18150 |
Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis
Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis |
|
https://doi.org/10.18632/oncotarget.4098
Gui-Qi Zhu,
Ke-Qing Shi,
Hua-Jian Yu,
Sun-Yue He,
Martin Braddock,
Meng-Tao Zhou,
Yong-Ping Chen,
and Ming-Hua Zheng
|
| 18151-18161 |
Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial
Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial |
|
https://doi.org/10.18632/oncotarget.4216
Jack P. Wang,
Chen-Yi Wu,
Yi-Cheng Yeh,
Yi-Ming Shyr,
Ying-Ying Wu,
Chen-Yu Kuo,
Yi-Ping Hung,
Ming-Huang Chen,
Wei-Ping Lee,
Jiing-Chyuan Luo,
Yee Chao,
and Chung-Pin Li
|
| 18162-18173 |
Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy
Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy |
|
https://doi.org/10.18632/oncotarget.4225
Sheng Chen,
Liang Huang,
Can-Ming Chen,
and Zhi-Ming Shao
|
| 18174-18182 |
Dose coverage of axillary level I-III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patients
Dose coverage of axillary level I-III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patients |
|
https://doi.org/10.18632/oncotarget.4301
Li Zhang,
Zhao-zhi Yang,
Xing-xing Chen,
Jeffrey Tuan,
Jin-li Ma,
Xin Mei,
Xiao-li Yu,
Zhi-rui Zhou,
Zhi-min Shao,
Guang-yu Liu,
and Xiao-mao Guo
|
| 18183-18191 |
Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.4145
Michal Podrazil,
Rudolf Horvath,
Etienne Becht,
Daniela Rozkova,
Pavla Bilkova,
Hana Hromadkova,
Jana Kayserova,
Katerina Vavrova,
Jan Lastovicka,
Petra Vrabcova,
Katerina Kubackova,
Zdenka Gasova,
Ladislav Jarolim,
Marek Babjuk,
Radek Spisek,
Jirina Bartunkova,
and Jitka Fucikova
|
| 18192-18205 |
Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer?
Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer? |
|
https://doi.org/10.18632/oncotarget.4524
Shuai Wang,
Zhe Yang,
and Zhou Wang
|
| 18206-18223 |
Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity
Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity |
|
https://doi.org/10.18632/oncotarget.4015
Inga Grünewald,
Claudia Vollbrecht,
Jeannine Meinrath,
Moritz F. Meyer,
Lukas C. Heukamp,
Uta Drebber,
Alexander Quaas,
Dirk Beutner,
Karl-Bernd Hüttenbrink,
Eva Wardelmann,
Wolfgang Hartmann,
Reinhard Büttner,
Margarete Odenthal,
and Markus Stenner
|
| 18224-18237 |
